1 / 6

Keep in Mind

Join Bette Meek from Health Canada for a discussion on the development of the comprehensive evaluation tool (ComET) focusing on substances. Explore future directions, applications, and efficiency improvements. Your input is valuable!

covingtonj
Download Presentation

Keep in Mind

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ComET Peer Input Meeting Path Forward Nov. 8th, 2004Bette Meek, Health Canadawww.hc-sc.gc.ca/exsd-dse

  2. Keep in Mind • Development of this “tool” (ComET) is a work in progress • Default values provided principally as examples, for illustration, currently • Not encompassing at this stage • Continuing suggestions are welcome, but this is NOT peer review • Deadline will determine form of peer review pre 2006 • It is the “tool” (ComET) which is the focus of this meeting, not the substances • Substances for illustrative purposes, only • “Tool” currently a spreadsheet but form will change

  3. Where to From Here? • Expansion of numbers of scenarios to be encompassing for substances in the program • Application of tool to remainder of substances on the high and mid groups of the maximal list • Where data/information will help • Development of a more efficient platform (moving from Access/Excel) • Data entry aids, menu selections • Review/revision of specific scenarios • Consistency

  4. Additionally Focussing Effort – the Maximal List • Focus on 1573 substances in “high” and “mid” groups • Subset of 314 substances in the “high” likelihood group, identified on basis of hazard for which exposure is low • Risk management in place? • Subset of 388 substances in the “mid” likelihood group for which determinations of persistence or bioaccumulation will contribute • Data limited for certain types of substances • UVCBs, polymers • To extent possible, will identify the more limited numbers of substances for which additional information on toxicity will be helpful

  5. Current Path/Timeline

  6. More Information? • Health Canada Existing Substances Division Website – http://www.hc-sc.gc.ca/exsd-dse • Health Canada Existing Substances Mailing List – http://www.hc-sc.gc.ca/hecs-sesc/exsd/listserv.htm • CEPA Registry – (http://www.ec.gc.ca/CEPARegistry)

More Related